Complex gene-gene interactions in multiple sclerosis: A multifactorial approach reveals associations with inflammatory genes

Neurogenetics

Volumn 8, Issue 1, 2007, Pages 11-20

  Motsinger, Alison A ^a   Brassat, David ^b   Caillier, Stacy J ^b   Erlich, Henry A ^c   Walker, Karen ^c   Steiner, Lori L ^c   Barcellos, Lisa F ^d   Pericak Vance, Margaret A ^e   Schmidt, Silke ^e   Gregory, Simon ^e   Hauser, Stephen L ^b   Haines, Jonathan L ^a   Oksenberg, Jorge R ^b   Ritchie, Marylyn D ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epistasis; Multifactor dimensionality reduction; Multiple sclerosis

Indexed keywords

ACCURACY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; GENE; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENETIC EPISTASIS; GENETIC RISK; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; GENOTYPE; HUMANS; INFLAMMATION; MODELS, GENETIC; MULTIPLE SCLEROSIS; PROTEINS;

EID: 33845669548     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-006-0058-9     Document Type: Article

References (41)

1. Hauser SL, Goodin DS (2005) Multiple sclerosis and other demyelinating diseases. In: Kasper DL, Braunwalk E, Fauci AD, Hauser SL, Longo DL, Jameson JL (eds) Harrison's principle of internal medicine, 16th edn. McGraw-Hill, New York
2. Oksenberg JR, Barcellos LF (2005) Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 6:375-387
3. Ebers G (1999) Modelling multiple sclerosis. Nat Genet 23:258-259
4. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469-471
5. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER et al (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 7:1229-1234
6. Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR, Hauser SL et al (2006) Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44. Genes Immun 7:73-76
7. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J et al (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464-468
8. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A et al (2005) A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 77:454-467
9. Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S et al (2002) Genetic basis for clinical expression in multiple sclerosis. Brain 125:150-158
10. Bellman R (1961) Adaptive control processes. Princeton University Press, Princeton
11. Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201-210
12. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373-1379
13. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF et al (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-147
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
15. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E et al (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710-716
16. Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19:376-382
17. Ritchie MD, Hahn LW, Moore JH (2003) Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24:150-157
18. Japkowicz N, Stephen S (2002) The class imbalance problem: a systematic study. Intelligent Data Analysis 6:429-450
19. Weiss GM, Provost F (2003) Learning when training data are costly: the effect of class distribution on tree induction. J Artif Intell Res 19:315-354
20. McDonnell GV, Kirk CW, Hawkins SA, Graham CA (2000) An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J Neurol Sci 176:4-12
21. Reboul J, Mertens C, Levillayer F, Eichenbaum-Voline S, Vilkoren T, Cournu I et al (2000) Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group. J Neuroimmunol 102:107-112
22. Vandenbroeck K, Martino G, Marrosu M, Consiglio A, Zaffaroni M, Vaccargiu S et al (1997) Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol 76:189-192
23. Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S et al (2004) Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 55:793-800
24. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P (2005) A haplotype map of the human genome. Nature 437:1299-1320
25. Candelaria PV, Backer V, Laing IA, Porsbjerg C, Nepper-Christensen S, de Klerk N et al (2005) Association between asthma-related phenotypes and the CC16 A38G polymorphism in an unselected population of young adult Danes. Immunogenetics 57:25-32
26. Menegatti E, Nardacchione A, Alpa M, Agnes C, Rossi D, Chiara M et al (2002) Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy. Lab Invest 82:543-546
27. Ohchi T, Shijubo N, Kawabata I, Ichimiya S, Inomata S, Yamaguchi A et al (2004) Polymorphism of Clara cell 10-kD protein gene of sarcoidosis. Am J Respir Crit Care Med 169:180-186
28. Ray R, Choi M, Zhang Z, Silverman GA, Askew D, Mukherjee AB (2005) Uteroglobin suppresses SCCA gene expression associated with allergic asthma. J Biol Chem 280:9761-9764
29. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG et al (2004) Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 50:43-54
30. Hung CH, Chen LC, Zhang Z, Chowdhury B, Lee WL, Plunkett B et al (2004) Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein. J Allergy Clin Immunol 114:664-670
31. Zhang Z, Kundu GC, Zheng F, Yuan CJ, Lee E, Westphal H et al (2000) Insight into the physiological function(s) of uteroglobin by gene-knockout and antisense-transgenic approaches. Ann N Y Acad Sci 923:210-233
32. Lucchinetti CF, Parisi J, Bruck W (2005) The pathology of multiple sclerosis. Neurol Clin 23:77-105, vi
33. Zhang Y, Da RR, Hilgenberg LG, Tourtellotte WW, Sobel RA, Smith MA et al (2005) Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol 167:120-130
34. Loza MJ, Foster S, Peters SP, Penn RB (2006) Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 107:2052-2060
35. Loop T, Bross T, Humar M, Hoetzel A, Schmidt R, Pahl HL et al (2004) Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro. Anesth Analg 99:1508-1515
36. Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B et al (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell 14:303-317
37. Chorley BN, Li Y, Fang S, Park JA, Adler KB (2006) (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol 34:119-127
38. Martin ER, Ritchie MD, Hahn LW, Kang S, Moore JH (2005) A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet Epidemiol (in press)
39. Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL et al (2006) Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun 7:310-315
40. Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A et al (2005) A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 37:1113-1118
41. Templeton A (2000) Epistasis and complex traits. In: Wade M, Broadie B III, Wolf J (eds) Epistasis and the evolutionary process. Oxford University Press, Oxford, pp 41-57